Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,989
Closed -$298K 112
2024
Q4
$298K Sell
2,989
-1,517
-34% -$156K 0.14% 90
2024
Q3
$470K Sell
4,506
-78
-2% -$9.27K 0.23% 66
2024
Q2
$570K Buy
4,584
+425
+10% +$54.7K 0.29% 51
2024
Q1
$542K Buy
4,159
+318
+8% +$39.2K 0.29% 52
2023
Q4
$451K Buy
3,841
+711
+23% +$73.8K 0.27% 55
2023
Q3
$319K Buy
3,130
+8
+0.3% +$862 0.21% 65
2023
Q2
$331K Buy
3,122
+61
+2% +$6.93K 0.21% 62
2023
Q1
$326K Sell
3,061
-760
-20% -$82.1K 0.24% 60
2022
Q4
$424K Buy
+3,821
New +$391K 0.3% 53

Other funds holding MRK

FWG Holdings's MRK Position: Q1 2025 in Review

FWG Holdings sold out of Merck (MRK) in Q1 2025, closing a stake of 2,989 shares — an estimated $298K sold.

FWG Holdings first reported a position in MRK in Q4 2022 and held it in 9 quarters. The position peaked at $570K in Q2 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • FWG Holdings reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • FWG Holdings sold 2,989 Merck shares in Q1 2025, an estimated $298K.
  • FWG Holdings first reported a position in Merck in Q4 2022 and held it in 9 quarters.
  • FWG Holdings's Merck position peaked at $570K in Q2 2024.
  • 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on FWG Holdings's 13F filing for Q1 2025, filed 2 May 2025.